Directorio

Rojas, P.*, Jung-Cook, H., Ruiz-Sánchez, E., Rojas-Tomé, I. S., Rojas, C., López-Ramírez, A. M., & Reséndiz-Albor, A. A. (2022). Historical Aspects of Herbal Use and Comparison of Current Regulations of Herbal Products between Mexico, Canada and the United States of America. International Journal of Environmental Research and Public Health, 19(23), 15690.
DOI:10.3390/ijerph192315690

Pech-Santiago, E. O., Argüello-García, R., Vázquez, C., Saavedra, E., González-Hernández, I., Jung-Cook, H., Rafferty, S. P., & Ortega-Pierres, M. G.* (2022). Giardia duodenalis: Flavohemoglobin is involved in drug biotransformation and resistance to albendazole. PLOS Pathogens, 18(9), e1010840.
DOI:10.1371/journal.ppat.1010840

López-Méndez, L. J., Palomares-Alonso, F., González-Hernández, I., Jung-Cook, H., Cabrera-Quiñones, N. C., & Guadarrama, P.* (2022). β-cyclodextrin dendritic derivatives as permeation mediators to enhance the in vitro albendazole cysticidal activity by the improvement of the diffusion component. RSC Advances, 12(36), 23153-23161.
DOI:10.1039/d2ra03314c

de Leon, J.*, Schoretsanitis, G., Smith, R. L., Molden, E., Solismaa, A., Seppälä, N., Kopeček, M., Švancer, P., Olmos, I., Ricciardi, C., Iglesias-Garcia, C., Iglesias-Alonso, A., Spina, E., Ruan, C. J., Wang, C. Y., Wang, G., Tang, Y. L., Lin, S. K., Lane, H. Y., Kim, Y. S., Kim, S. H., Rajkumar, A. P., González-Esquivel, D. F., Jung-Cook, H., . . . Müller, D. J. (2022). An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. Pharmacopsychiatry, 55(02), 73-86.
DOI:10.1055/a-1625-6388

Fricke-Galindo, I., Jung-Cook, H., Martínez-Juárez, I. E., Monroy-Jaramillo, N., Ortega-Vázquez, A., Rojas-Tomé, I. S., Dorado, P., Peñas-Lledó, E., Llerena, A., & López-López, M. (2021). Relevance of NR1I2 variants on carbamazepine therapy in Mexican Mestizos with epilepsy at a tertiary-care hospital. Pharmacogenomics, 22(15), 983–996.
DOI:10.2217/pgs-2021-0081

Pérez-Osorio, I. N., Espinosa, A., Giraldo Velázquez, M., Padilla, P., Bárcena, B., Fragoso, G., Jung-Cook, H., Besedovsky, H., Meneses, G., & Sciutto Conde, E. L.* (2021). Nose-to-Brain Delivery of Dexamethasone: Biodistribution Studies in Mice. Journal of Pharmacology and Experimental Therapeutics, 378(3), 244–250.
DOI:10.1124/jpet.121.000530

de Leon, J.*, Schoretsanitis, G., Smith, R. L., Molden, E., Solismaa, A., Seppälä, N., Kopeček, M., ŠVancer, P., Olmos, I., Ricciardi, C., Iglesias-Garcia, C., Iglesias-Alonso, A., Spina, E., Ruan, C. J., Wang, C. Y., Wang, G., Tang, Y. L., Lin, S. K., Lane, H. Y., Kim, Y. S., Kim, S. H., Rajkumar, A. P., González-Esquivel, D. F., Jung-Cook, H., . . ., & Müller, D. J. (2021). An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. Pharmacopsychiatry.
DOI:10.1055/a-1625-6388

González-Esquivel, D. F., Jung-Cook, H., Baptista, T., & de Leon, J.* (2021). Amerindians may need clozapine dosing similar to that of Asians. [Los amerindios pueden necesitar las mismas bajas dosis de clozapina que los asiáticos] Revista De Psiquiatria y Salud Mental, 14(3), 177-179.
DOI:10.1016/j.rpsm.2020.11.002

Mayet-Cruz, L., Rodríguez, J. M., & Jung-Cook, H.* (2021). Development of a dissolution test for melatonin sublingual tablets using a factorial experimental design. Farmacia, 69(1), 169-173.
DOI:10.31925/farmacia.2021.1.23

Miranda-Pérez de Alejo, C., Aceituno Álvarez, A., Mendes Lima Santos, G., Fernández Cervera, M., Jung-Cook, H., & Cabrera-Pérez, M. Á. (2021). Policy of Multisource Drug Products in Latin America: Opportunities and Challenges on the Application of Bioequivalence In Vitro Assays. Therapeutic Innovation and Regulatory Science, 55(1), 65-81.
DOI:10.1007/s43441-020-00191-7

González-Esquivel, D. F., Jung-Cook, H., Baptista, T., & de Leon, J.* (2020). Amerindians may need clozapine dosing similar to that of Asians. [Los amerindios pueden necesitar las mismas bajas dosis de clozapina que los asiáticos]. Revista De Psiquiatria y Salud Mental.
DOI:10.1016/j.rpsm.2020.11.002

Mena-Hernández, J., Jung-Cook, H., Llaguno-Munive, M., García-López, P., Ganem-Rondero, A., López-Ramírez, S., Barragán-Aroche, F.f, Rivera-Huerta, M., & Mayet-Cruz, L. (2020). Preparation and Evaluation of Mebendazole Microemulsion for Intranasal Delivery: an Alternative Approach for Glioblastoma Treatment. AAPS PharmSciTech, 21(7).
DOI:10.1208/s12249-020-01805-x

Hernández-Pineda, J., Jung-Cook, H. H., Katende-Kyenda, N. L., Galindo-Sevilla, N., Domínguez-Castro, M., Romo-Yañéz, J., Ramírez-Ramírez, A., Irles, C., & Figueroa-Damián, R. (2020). Assessment of lamivudine, zidovudine, lopinavir, and ritonavir plasma levels in HIV-positive pregnant women: Drug monitoring application to improve patient safety. Medicine, 99(22), e20487.
DOI:10.1097/MD.0000000000020487

Miranda-Pérez de Alejo, C., Aceituno Álvarez, A., Mendes Lima Santos, G., Fernández Cervera, M., Jung-Cook, H., & Cabrera-Pérez, M. Á. (2020). Policy of Multisource Drug Products in Latin America: Opportunities and Challenges on the Application of Bioequivalence In Vitro Assays. Therapeutic Innovation and Regulatory Science.
DOI:10.1007/s43441-020-00191-7

Ortega-Vázquez, A., Fricke-Galindo, I., Dorado, P., Jung-Cook, H., Martínez-Juárez, I. E., Monroy-Jaramillo, N., Rojas-Tomé, I. S., Peñas-Lledó, E., Llerena, A., & López-López, M. (2020). Influence of genetic variants and antiepileptic drug co-treatment on lamotrigine plasma concentration in Mexican Mestizo patients with epilepsy. Pharmacogenomics Journal.
DOI:10.1038/s41397-020-0173-2

Medina-López, R., Arregui, E. E., Aranda, E. J., Moreno-Rocha, L. A., Hurtado, M., Jung-Cook, H., & Helmy, S. A. (2020). Logic of Selecting Suitable Dissolution Parameters in New Drug Formulations Based on A BCS Approach. Iranian Journal of Pharmaceutical Research, 19(1), 465-486.
DOI:10.22037/ijpr.2020.1100993

Reséndiz-Galván, J. E., Romano-Aguilar, M., Medellín-Garibay, S. E., Milán-Segovia, R. del C., Niño-Moreno, P. del C., Jung-Cook, H., Chevaile-Ramos, J. A., & Romano-Moreno, S. (2020). Population pharmacokinetics of mycophenolic acid in adult kidney transplant patients under prednisone and tacrolimus regimen. European Journal of Pharmaceutical Sciences, 150, 105370.
DOI:10.1016/j.ejps.2020.105370

Hernández-Mitre, M. P., Medellín-Garibay, S. E., Rodríguez-Leyva, I., Rodríguez-Pinal, C. J., Zarazúa, S., Jung-Cook, H. H., Roberts, J. A., Romano-Moreno, S., & Milán-Segovia, R. del C. (2020). Population Pharmacokinetics and Dosing Recommendations of Levetiracetam in Adult and Elderly Patients With Epilepsy. Journal of Pharmaceutical Sciences, 109(6), 2070-2078.
DOI:10.1016/j.xphs.2020.02.018

Palomares-Alonso, F., Toledo, A., Palencia Hernández, G., Jung-Cook, H., & Fleury, A. (2020). Effect of dexamethasone on albendazole cysticidal activity in experimental cysticercosis by taenia crassiceps in BALB/c mice: In vitro and in vivo evaluation. Experimental Parasitology, 208.
DOI:10.1016/j.exppara.2019.107801

Rodrigues-Soares, F., Peñas-Lledó, E. M., Tarazona-Santos, E., Sosa-Macías, M., Terán, E., López-López, M., Rodeiro, I., Moya, G. E., Calzadilla, L. R., Ramírez-Roa, R., Grazina, M., Estévez-Carrizo, F. E., Barrantes, R., LLerena, A., Tinoco, C. A., Álvárez, M., Borbón, A., Céspedes-Garro, C., Cobaleda, J., de Andrés, F., Delgado, R., Dorado, P., Fariñas, H., Ferreiro, V., Fricke-Galindo, I., Galaviz-Hernández, C., Garza-Ocañas, L., Gilman, R. H., Hernández, F., Jiménez-Arce, G., Jung-Cook, H., Lares-Aseff, I., Lazalde-Ramos, B. P., Michelin, L., Monroy-Jaramillo, N., Naranjo, M. E. G., Ortega-Vázquez, A., Ortiz-López, R., Pérez, B., Pérez-Páramo, Y. X., Remirez, D., Rojas-Martínez, A., Sarmiento, A. P., Scliar, M., Terán, S., Zamudio, R., & RIBEF Ibero-American Network of Pharmacogenetics and Pharmacogenomics. (2020). Genomic ancestry, CYP2D6, CYP2C9, and CYP2C19 among latin americans. Clinical Pharmacology and Therapeutics, 107(1), 257-268.
DOI:10.1002/cpt.1598

González-Hernández, I., Palomares-Alonso, F., Becerril-Vega, J., De La Torre, S. M., Hernández-Luis, F., Rodriguez-Morales, S., Aguayo-Ortiz, R., Dominguez, L., Rodríguez-Balderas, C. A., González-Maciel, A., Rojas-Tomé, I. S., Castro, N., & Jung-Cook, H. (2019). Evaluation of new benzimidazole derivatives as cysticidal agents: In vitro, in vivo and docking studies. Chemical and Pharmaceutical Bulletin, 67(12), 1293-1300.
DOI:10.1248/cpb.c19-00574

Jung-Cook, H., Mayet-Cruz, L., & Girard-Cuesy, M. E. (2018). Comparative in vitro dissolution and in vivo bioavailability of commercial amlodipine tablets. Tropical Journal of Pharmaceutical Research, 17(9), 1685-1691.
DOI:10.4314/tjpr.v17i9.1

Fricke-Galindo, I., LLerena, A., Jung-Cook, H., & López-López, M. (2018). Carbamazepine adverse drug reactions. Expert Review of Clinical Pharmacology, 11(7), 705-718.
DOI:10.1080/17512433.2018.1486707

Fricke-Galindo, I., Jung-Cook, H., LLerena, A., & López-López, M. (2018). Pharmacogenetics of adverse reactions to antiepileptic drugs. [Farmacogenética de reacciones adversas a fármacos antiepilépticos] Neurologia, 33(3), 165-176.
DOI:10.1016/j.nrl.2015.03.005

de la Fuente-Sandoval, C., Reyes-Madrigal, F., Mao, X., León-Ortiz, P., Rodríguez-Mayoral, O., Jung-Cook, H., Solís-Vivanco, R., Graff-Guerrero, A., & Shungu, D. C. (2018). Prefrontal and striatal gamma-aminobutyric acid levels and the effect of antipsychotic treatment in first-episode psychosis patients. Biological Psychiatry, 83(6), 475-483.
DOI:10.1016/j.biopsych.2017.09.028

Palomares-Alonso, F., Rojas-Tomé, I. S., Palencia Hernández, G., Jiménez-Arellanes, M. A., Macías-Rubalcava, M. L., González-Maciel, A., Ramos-Morales, A., Santiago-Reyes, R., Castro, N., González-Hernández, I., Rufino-González, Y., & Jung-Cook, H. (2017). In vitro and in vivo cysticidal activity of extracts and isolated flavanone from the bark of prunus serotina: A bio-guided study. Acta Tropica, 170, 1-7.
DOI:10.1016/j.actatropica.2017.02.023

Ruiz-Olmedo, M. I., González-Hernández, I., Palomares-Alonso, F., Franco-Pérez, J., González F., M. D. L., & Jung-Cook, H. (2017). Effect of nitazoxanide on albendazole pharmacokinetics in cerebrospinal fluid and plasma in rats. Saudi Pharmaceutical Journal, 25(3), 413-418.
DOI:10.1016/j.jsps.2016.09.005

Flores-Ramos, M., Ibarra-Velarde, F., Jung-Cook, H., Hernández-Campos, A., Vera-Montenegro, Y., & Castillo, R. (2017). Novel triclabendazole prodrug: A highly water soluble alternative for the treatment of fasciolosis. Bioorganic and Medicinal Chemistry Letters, 27(3), 616-619.
DOI:10.1016/j.bmcl.2016.12.004

Fricke-Galindo, I., Ortega-Vázquez, A., Monroy-Jaramillo, N., Dorado, P., Jung-Cook, H., Peñas-Lledó, E., Llerena, A., & López-López, M. (2016). Allele and genotype frequencies of genes relevant to anti-epileptic drug therapy in mexican-mestizo healthy volunteers. Pharmacogenomics, 17(17), 1913-1930.
DOI:10.2217/pgs-2016-0078

Sosa-Macías, M., Teran, E., Waters, W., Fors, M. M., Altamirano, C., Jung-Cook, H., Galaviz-Hernández, C., López-López, M., Remírez, D., Moya, G. E., Hernández, F., Fariñas, H., Ramírez, R., Céspedes-Garro, C., Tarazona-Santos, E., & Llerena, A. (2016). Pharmacogenetics and ethnicity: Relevance for clinical implementation, clinical trials, pharmacovigilance and drug regulation in latin america. Pharmacogenomics, 17(16), 1741-1747.
DOI:10.2217/pgs-2016-0153

Fricke-Galindo, I., Jung-Cook, H., Llerena, A., & López-López, M. (2016). Interethnic variability of pharmacogenetic biomarkers in mexican healthy volunteers: A report from the RIBEF (ibero-american network of pharmacogenetics and pharmacogenomics). Drug Metabolism and Personalized Therapy, 31(2), 61-81.
DOI:10.1515/dmpt-2015-0030

Guerrero Garduño, O., González-Esquivel, D. F., Escalante-Membrillo, C., Fernández, A., Rojas-Tomé, I. S., Jung Cook, H., & Castro, N. (2016). Comparison of a high-performance liquid chromatography method for quantification of carbamazepine with chemiluminescent microparticle immunoassay. Biomedical Chromatography, 30(6), 933-937.
DOI:10.1002/bmc.3631

Ortega-Vázquez, A., Dorado, P., Fricke-Galindo, I., Jung-Cook, H., Monroy-Jaramillo, N., Martínez-Juárez, I. E., Familiar-López, I., Peñas-Lledó, E., Llerena, A., & López-López, M. (2016). CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in mexican-mestizo patients with epilepsy. Pharmacogenomics Journal, 16(3), 286-292.
DOI:10.1038/tpj.2015.45

Sánchez-Guadarrama, O., Mendoza-Navarro, F., Cedillo-Cruz, A., Jung-Cook, H., Arenas-García, J. I., Delgado-Díaz, A., Herrera-Ruiz, D., Morales-Rojas, H., & Höpfl, H. (2016). Chiral resolution of RS-praziquantel via diastereomeric co-crystal pair formation with l -malic acid. Crystal Growth and Design, 16(1), 307-314.
DOI:10.1021/acs.cgd.5b01254

Mendoza-Macedo, K., Romero-Díaz, A. J., Miranda-Hernández, M. P., Campos-García, V. R., Ramírez-Ibañez, N. D., Juárez-Bayardo, L. C., Moreno-Duran, K., Cedillo-Robles, M. S., Pérez, N. O., Jung-Cook, H., Flores-Ortiz, L. F., & Medina-Rivero, E. (2016). Characterization and comparability of biosimilars: A filgrastim case of study and regulatory perspectives for latin america. Electronic Journal of Biotechnology, 24, 63-69.
DOI:10.1016/j.ejbt.2016.10.003